This federal contract award is for the delivery of Bydureon BCISE 2 mg autoinject 0.85 ml, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 20, 2024 with a ceiling value of $10,173.75. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 23, 2024. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/21/25, 10:02 AM